Biochemistry, Genetics and Molecular Biology
Methylation
100%
DNA Methylation
98%
Epigenetics
59%
CpG Island
35%
Promoter Region
32%
Cancer Cell
30%
Microarrays
26%
Gene Expression
20%
Mouse
19%
B Cell
17%
CpG Site
16%
Bisulfite Sequencing
15%
Cancer Stem Cell
15%
Methylome
12%
Enhancer Region
12%
T Cell
10%
DNMT1
10%
Bisulfite
10%
Next Generation Sequencing
10%
Carcinogenesis
9%
Gene Promoter
9%
Stem Cell
9%
Epigenetic Modification
8%
Transcription
8%
DNA Methyltransferase
8%
Epigenome
8%
Epigenomics
8%
Signal Transduction
7%
Upregulation
7%
Polymerase Chain Reaction
7%
Leukocyte
7%
Progenitor Cell
7%
Thermogenesis
7%
Myeloid
7%
Adipocyte
7%
Mouse Model
6%
Cytosine
6%
Differentially Methylated Regions
6%
Neutrophil Granulocyte
6%
Decitabine
6%
MicroRNA
6%
Histone Methyltransferase
5%
Angiogenesis
5%
Anabolism
5%
Gene Control
5%
Epigenetics
5%
Tumor Progression
5%
Regulatory Region
5%
Protein Expression
5%
Histone Modification
5%
Keyphrases
DNA Methylation (DNAm)
68%
Methylation
48%
CpG Island
31%
Differential Methylation
22%
Epigenetic Modification
21%
Obesity
20%
Microarray
20%
DNA Methyltransferase 1 (DNMT1)
19%
Hypermethylation
19%
Tumor
19%
Chronic Lymphocytic Leukemia
18%
In Cancer
16%
CpG Sites
16%
Methylation Status
15%
Promoter Methylation
15%
DNA Methylation Analysis
15%
Bisulfite Sequencing
14%
Gene Expression
14%
Tumor Cells
13%
Epigenetics
12%
Non-Hodgkin Lymphoma
12%
Differentially Methylated Regions
12%
Gene Promoter
11%
Follicular Lymphoma
10%
Neutrophils
10%
Cytotoxic T Lymphocytes
10%
CpG Island Methylation
9%
DNA Methyltransferase 3B (DNMT3B)
9%
DNA Methylation Pattern
9%
Hypermethylated
9%
Genome-wide DNA Methylation
9%
Transcription Factor
9%
Programmed Death-ligand 1 (PD-L1)
9%
Methylation Changes
9%
5-aza-2′-deoxycytidine
9%
Methylome
9%
Butyrate
8%
Breast Cancer
8%
Next-generation Sequencing
8%
Tumorigenesis
8%
Computational Methods
8%
Leukemia Patients
8%
MicroRNA
8%
Indoleamine 2,3-dioxygenase 1 (IDO1)
7%
Brown Fat
7%
Genome-wide Methylation
7%
Cancer Stem Cells
7%
2-hydroxybutyric Acid
7%
Optofluidic Ring Resonator
7%
Cancer Cells
7%